Case report A 22 year old woman, who had never had asthma, was admitted to hospital in June 1987 with recurrent fever, lymphadenopathy, and severe anaemia. She had been well until two months before admission, when isolated severe anaemia developed and a bone marrow aspiration showed the characteristic features of pure red cell aplasia. At that time neither fever nor lymphadenopathy was present, and several units of packed red cells were transfused.
On admission the only abnormal findings were pallor and diffuse lymphadenopathy. Her haemoglobin was origin of bronchocentric granulomatosis in this latter group remains unknown. Our patient was not asthmatic and lacked evidence of hypersensitivity to fungi. An invasive infection was excluded by vigorous investigation.
Extrapulmonary features were originally considered not to be part of the spectrum of bronchocentric granulomatosis; but several case reports since the original report have Although mild to moderate anaemia is common in patients with bronchocentric granulomatosis, severe anaemia due to pure red cell aplasia has not previously been described in this condition. Pure red cell aplasia is an uncommon disease for which an autoimmune aetiology has been proposed in view of the presence of serum immunoglobulin inhibitors of erythropoiesis in many patients and the frequent association ofthe condition with other immune disorders.'0 The association of fever and lymphadenopathy with pure red cell aplasia in our patient may suggest a common infectious (presumably viral) pathogenesis. Nevertheless, the following facts argue against this origin: (1) the appearance of lymphadenopathy and fever two months after the diagnosis of pure red cell aplasia was made; (2) the chronic course of the severe anaemia; (3) no evidence of acute infection from sequential tests for serum antibodies to multiple viruses; and (4) the excellent response to corticosteroid treatment.
Although we cannot exclude a causal relation, the temporal association of pure red cell aplasia, lymphadenopathy and prolonged fever with bronchocentric granulomatosis in our patient, and the rapid resolution of all features with corticosteroid treatment, supports the idea that bronchocentric granulomatosis is part of a systemic disease process, as suggested by others.' We suggest that both bronchocentric granulomatosis and extrapulmonary disease might reflect a widespread disordered immunological reaction to an as yet unidentified antigen. The association of bronchocentric granulomatosis with pure red cell aplasia, a disorder for which an autoimmune pathogenesis has been proposed, would seem to support our hypothesis. Further studies are needed to identify the antigen responsible and assess the immune system in patients with bronchocentric granulomatosis, especially in those patients with associated extrapulmonary features.
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